114 related articles for article (PubMed ID: 28643743)
21. Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer.
Wang H; Zhang X; Wang L; Zheng G; Du L; Yang Y; Dong Z; Liu Y; Qu A; Wang C
J Surg Oncol; 2014 May; 109(6):574-9. PubMed ID: 24338523
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer.
Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C
Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713
[TBL] [Abstract][Full Text] [Related]
23. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma.
Kantola T; Klintrup K; Väyrynen JP; Vornanen J; Bloigu R; Karhu T; Herzig KH; Näpänkangas J; Mäkelä J; Karttunen TJ; Tuomisto A; Mäkinen MJ
Br J Cancer; 2012 Nov; 107(10):1729-36. PubMed ID: 23059742
[TBL] [Abstract][Full Text] [Related]
24. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P
Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834
[TBL] [Abstract][Full Text] [Related]
25. Elevated systemic interleukin-7 in patients with colorectal cancer and individuals at high risk of cancer: association with lymph node involvement and tumor location in the right colon.
Krzystek-Korpacka M; Zawadzki M; Neubauer K; Bednarz-Misa I; Górska S; Wiśniewski J; Witkiewicz W; Gamian A
Cancer Immunol Immunother; 2017 Feb; 66(2):171-179. PubMed ID: 27866242
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of serum angiogenic activity in colorectal cancer patients.
Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of plasma ORM2 levels in patients with stage II colorectal cancer.
Gao F; Zhang X; Whang S; Zheng C
Ann Clin Lab Sci; 2014; 44(4):388-93. PubMed ID: 25361921
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of serum adipokine levels in colorectal cancer patients.
Guadagni F; Roselli M; Martini F; Spila A; Riondino S; D'Alessandro R; Del Monte G; Formica V; Laudisi A; Portarena I; Palmirotta R; Ferroni P
Anticancer Res; 2009 Aug; 29(8):3321-7. PubMed ID: 19661351
[TBL] [Abstract][Full Text] [Related]
29. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
[TBL] [Abstract][Full Text] [Related]
30. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
[TBL] [Abstract][Full Text] [Related]
31. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
32. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
Jobin G; Rodriguez-Suarez R; Betito K
Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
[TBL] [Abstract][Full Text] [Related]
33. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
[TBL] [Abstract][Full Text] [Related]
34. Cytokeratin serum biomarkers in patients with colorectal cancer.
Holdenrieder S; Stieber P; Liska V; Treska V; Topolcan O; Dreslerova J; Matejka VM; Finek J; Holubec L
Anticancer Res; 2012 May; 32(5):1971-6. PubMed ID: 22593474
[TBL] [Abstract][Full Text] [Related]
35. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
[TBL] [Abstract][Full Text] [Related]
36. Association between serum angiopoietin-2 concentration and clinicopathological parameters in patients with colorectal cancer.
Wang ZQ; Sun XL; Su HL; Liu XF; Xuan YJ; Yu SQ
Genet Mol Res; 2015 Dec; 14(4):15547-52. PubMed ID: 26634521
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of novel adipocytokines in patients with colorectal cancer.
Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
[TBL] [Abstract][Full Text] [Related]
38. Low serum interleukin-13 levels correlate with poorer prognoses for colorectal cancer patients.
Saigusa S; Tanaka K; Inoue Y; Toiyama Y; Okugawa Y; Iwata T; Mohri Y; Kusunoki M
Int Surg; 2014; 99(3):223-9. PubMed ID: 24833143
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
Abdulla MH; Valli-Mohammed MA; Al-Khayal K; Al Shkieh A; Zubaidi A; Ahmad R; Al-Saleh K; Al-Obeed O; McKerrow J
Oncol Rep; 2017 Jun; 37(6):3175-3180. PubMed ID: 28440429
[TBL] [Abstract][Full Text] [Related]
40. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
